advertisement

---

Berendschot TTJM 18

Showing records 1 to 18 | Display all abstracts from Berendschot TTJM

90568 XEN Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results
Scheres LMJ
Acta Ophthalmologica 2021; 99: e433-e440

---

90044 Micropulse Trans-scleral Cyclophotocoagulation in Patients With Glaucoma: 1- and 2-Year Treatment Outcomes
de Crom RMPC
Journal of Glaucoma 2020; 29: 794-798

---

90063 Contributing ocular comorbidity to end-of-life visual acuity in medically treated glaucoma patients, ocular hypertension and glaucoma suspect patients
Mokhles P
Eye 2021; 35: 883-891

---

90044 Micropulse Trans-scleral Cyclophotocoagulation in Patients With Glaucoma: 1- and 2-Year Treatment Outcomes
Slangen CGMM
Journal of Glaucoma 2020; 29: 794-798

---

90063 Contributing ocular comorbidity to end-of-life visual acuity in medically treated glaucoma patients, ocular hypertension and glaucoma suspect patients
van Gorcom L
Eye 2021; 35: 883-891

---

90568 XEN Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results
Kujovic-Aleksov S
Acta Ophthalmologica 2021; 99: e433-e440

---

90063 Contributing ocular comorbidity to end-of-life visual acuity in medically treated glaucoma patients, ocular hypertension and glaucoma suspect patients
Schouten JSAG
Eye 2021; 35: 883-891

---

90568 XEN Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results
Ramdas WD
Acta Ophthalmologica 2021; 99: e433-e440

---

90044 Micropulse Trans-scleral Cyclophotocoagulation in Patients With Glaucoma: 1- and 2-Year Treatment Outcomes
Kujovic-Aleksov S
Journal of Glaucoma 2020; 29: 794-798

---

90568 XEN Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results
de Crom RMPC
Acta Ophthalmologica 2021; 99: e433-e440

---

90044 Micropulse Trans-scleral Cyclophotocoagulation in Patients With Glaucoma: 1- and 2-Year Treatment Outcomes
Webers CAB
Journal of Glaucoma 2020; 29: 794-798

---

90063 Contributing ocular comorbidity to end-of-life visual acuity in medically treated glaucoma patients, ocular hypertension and glaucoma suspect patients
Berendschot TTJM
Eye 2021; 35: 883-891

---

90568 XEN Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results
Roelofs LCG
Acta Ophthalmologica 2021; 99: e433-e440

---

90044 Micropulse Trans-scleral Cyclophotocoagulation in Patients With Glaucoma: 1- and 2-Year Treatment Outcomes
Berendschot TTJM
Journal of Glaucoma 2020; 29: 794-798

---

90063 Contributing ocular comorbidity to end-of-life visual acuity in medically treated glaucoma patients, ocular hypertension and glaucoma suspect patients
Beckers HJM; Webers CAB
Eye 2021; 35: 883-891

---

90568 XEN Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results
Berendschot TTJM
Acta Ophthalmologica 2021; 99: e433-e440

---

90044 Micropulse Trans-scleral Cyclophotocoagulation in Patients With Glaucoma: 1- and 2-Year Treatment Outcomes
Beckers HJM
Journal of Glaucoma 2020; 29: 794-798

---

90568 XEN Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results
Webers CAB; Beckers HJM
Acta Ophthalmologica 2021; 99: e433-e440

---